These findings along with the observations from TREM2−/− PS19 mice support the distinct effects of TREM2 on microglial function in the presence of amyloid pathology versus tauopathy, adding layers of complexity about TREM2 and its role in AD pathogenesis. Here, TREM2 is linked to amyloidosis.